Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients

Author： Pfeiler G.   Glatz C.   Köönigsberg R.   Geisendorfer T.   Fink-Retter A.   Kubista E.   Singer C. F.   Seifert M.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.14, Iss.3, 2011-06, pp. : 339-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Menopausal-type symptoms among breast cancer patients on aromatase inhibitor therapy

By Gallicchio L.  

Climacteric, Vol. 15, Iss. 4, 2012-08 ,pp. : 339-349

Informa Healthcare

Access to resources Recommend Favorite

Use of aromatase inhibitors in gynecology

By Elnahhas Intisar M   Mitwally Mohamed F  

Expert Review of Obstretrics and Gynecology, Vol. 5, Iss. 2, 2010-03 ,pp. : 257-265

Informa Healthcare

Access to resources Recommend Favorite

The future for aromatase inhibitors is bright

By Vladimirov I.K.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1141-1141

Elsevier

Access to resources Recommend Favorite

Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy

By Jaisamrarn U.  

Climacteric, Vol. 16, Iss. 3, 2013-06 ,pp. : 347-355

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects

By Berstein L.   Maximov S.   Gershfeld E.   Meshkova I.   Gamajunova V.   Tsyrlina E.   Larionov A.   Kovalevskij A.   Vasilyev D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 105, Iss. 2, 2002-11 ,pp. : 161-165

Elsevier

Access to resources Recommend Favorite